chrisvoncsefalvay/vaers-outcomes huggingface dataset:
lack of energy/their strength in the right hand is gone; The weakness in the right hand is moving up their arm to their elbow now; the patient fatigues real easy now; left arm about 2 to 3 inches from the injection site a sore has opened up and clear liquid is coming out; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (lack of energy/their strength in the right hand is gone), MUSCULAR WEAKNESS (The weakness in the right hand is moving up their arm to their elbow now), FATIGUE (the patient fatigues real easy now) and VACCINATION SITE PAIN (left arm about 2 to 3 inches from the injection site a sore has opened up and clear liquid is coming out) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040C21A) for COVID-19 vaccination.     The patient's past medical history included Stroke. Concurrent medical conditions included Seizures, Pain and Paralyzed (Left side of their body is paralyzed.). Concomitant products included IBUPROFEN (ADVIL 12 HOUR) for Pain, PHENYTOIN for Seizures, PANTOPRAZOLE, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), ESCITALOPRAM and LOVASTATIN for an unknown indication.    On 01-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In August 2021, the patient experienced ASTHENIA (lack of energy/their strength in the right hand is gone), MUSCULAR WEAKNESS (The weakness in the right hand is moving up their arm to their elbow now), FATIGUE (the patient fatigues real easy now) and VACCINATION SITE PAIN (left arm about 2 to 3 inches from the injection site a sore has opened up and clear liquid is coming out). At the time of the report, ASTHENIA (lack of energy/their strength in the right hand is gone), MUSCULAR WEAKNESS (The weakness in the right hand is moving up their arm to their elbow now), FATIGUE (the patient fatigues real easy now) and VACCINATION SITE PAIN (left arm about 2 to 3 inches from the injection site a sore has opened up and clear liquid is coming out) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was reported.   Reporter did not allow further contact
at approx. 10:25 am had flu shot and about 3:30 pm my throat suddenly felt like it was closing and it was getting harder and harder to swallow as the night went on. I also experienced hoarseness. I went to the emergency room and was treated and release.
Rash Narrative:  Developed "walnut" sized rash over injection site that started a day after vaccination and lasted over a week. Associated with warmth, erythema and swelling. No induration or associated pain, no other adverse effects noted. Took acetaminophen, but she does not feel like it helped.
15NOV96 to MD office w/rash, sore throat, itchy ears ;pt given med;22NOV96 rash spread, cough, back psin, tingling in arm, could not feel feet;25NOV95 inc weakness;26NOV96 adm to hosp dx GBS, back pain, dermatitis & poss spinal cord compres
After the shot he had quite a bit of pain for 2 days on upper left arm where injection was given. There was no swelling or redness. The pain went down after 2 days but slowly came back again. Placed hot water pack on couple of times a day for 2 weeks but the pain did not go away. The pain got to the point where he was unable to lift anything heavy with lt hand, could not sleep on lt side, and could not lift arm fully. Dr recommended Motrin 800mg every 8hrs, cold packs to affected area as much as tolerated and limit use of muscle.
PRESENTING PROBLEM: Weakness   HOSPITAL COURSE: Patient is a 61-year-old male who was admitted on 11/11 for observation a weakness to work with PT and OT.  Patient was found to still be COVID-19 positive.   Recent medical history was that patient 1st became COVID-19 positive on 9/19 admitted for weakness related to this and discharged 9/24. Returned 10/04 admitted at hospital for bacterial pneumonia transferred to other facility for bronchoscopy, discharged to subacute rehab on 10/13.   Returned with weakness and intermittent fevers for the past 2 weeks. We consulted with ID who believes the COVID positive this admission is DNA fragments detected has cycle threshold was high consistent with a cleared infection.   Patient feels stronger, he has been eating and drinking well. He has been working closely with therapy team and initially they were recommending subacute rehab but today changing to home with home health care, PT, & OT.   Patient feels ready to go, vitals are stable though he has some mild tachycardia (ECG normal sinus, D-dimer is normal, no leukocytosis or fevers during admission). No changes to patient's chronic medications at discharge.   CONSULTS / RECOMMENDATION: See Infectious Disease Doctor's note on 11/15   Physical Exam at Discharge Temp 36.6°, heart rate 107, blood pressure 110/75, respiratory 18, oxygenation 92% on room air   Physical Exam Constitutional: Well nourished, no acute distress. Alert and oriented to person, place and time. Answering questions appropriately. Cardiovascular: Mild and regular rhythm. Pulmonary/Chest: Unlabored speech and respirations on room air. No use of accessory muscles. Clear lung sounds with no crackles or wheezes. Musculoskeletal: Moving all four extremities spontaneously. Integumentary: Warm, pink, and dry.  Neurological: No gross motor or sensory deficits.
second dose not scheduled, past 42 days; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose not scheduled, past 42 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose not scheduled, past 42 days). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose not scheduled, past 42 days) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided. Treatment information was not provided.   Reporter did not allow further contact
10 dys after smallpox, pt had diffuse erythematous papular rxn over chest, back and post neck. + pustular lesions x 4-5 with early crusting. No hx signif acne. Rxn most c/w erythematous papular E multiforme on CDC web site. Pt feels fine - will monitor for transition to progressive vaccinia. Tx Velosef to prevent 2 bacterial infxn.
Pt was given TD vaccine in left deltoid on 4/24/02 and was into the clinic on 5/1/02 with left arm 4 3/4" X 3/18" area of redness and swollen at deltoid site. Temperature was 99.4F. Pt was seen by PA and given Tylenol and Benadryl 25mg tid X 10 days.
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The HCF consulted with the local Dept of Public Health and Environment and did not recommend repeating this dose in question. No ill effect post administration was reported.
Patient has large red and raised area on right underarm. States painful and warm - with hardness lump at injection site. Erythema: 5-6in wide x 12 in long on 12/9/16.
Blood blisters on arm that was given the vaccine, dizzy/double vision, fatigue,  fever, swelling in face and legs, raspy throat, felt weak, vomiting.
I had extreme body aches, chills, fever up to 101.9, headaches. Nauseous after vaccine and vomiting
Very swollen lymph nodes; This is a spontaneous report from a contactable nurse (patient herself). A 34-year-old female patient (not pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration (left arm), on 20Jan2021 11:30, at single dose, for covid-19 immunization. Medical history included hypothyroid, insulin resistant, and tachycardia. The patient has no known allergies. The patient's concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), on 30Dec2020 19:00, vaccine location left arm, for covid-19 immunization at 34-years-old. The patient experienced very swollen lymph nodes on 21Jan2021 06:00 AM. The patient had not recovered from the event. It was unknown if treatment was received for the event. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have COVID prior vaccination and have not been COVID tested post vaccination.  Information about the lot/batch number has been requested.
This spontaneous case reported by a consumer, describes the occurrence of dysgeusia (metal taste in my mouth mainly when I eat canned tomatoes) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. Medical history not provided. On Jun 22, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced dysgeusia (metal taste in my mouth mainly when I eat canned tomatoes). At the time of the report, dysgeusia (metal taste in my mouth mainly when I eat canned tomatoes) outcome: unknown. No concomitant medication or treatment information reported. Action taken with mRNA-1273 in response to the events: not applicable.
Upon returning to her place of residence via personal vehicle (as a passenger), the vaccine recipient reported experiencing moderate-severe nausea without emesis. It was determined by her daughter, who is both a nurse and her primary caregiver that medicinal intervention was needed to relieve her symptoms. This event occurred roughly 30min after vaccine administration. About 10min after the initial complaint and 40min after vaccine administration, an antiemetic medication (Ondansetron) was provided by her daughter and this was noted to be successful as evidenced by the vaccine recipient reporting no further nausea or any other symptoms afterwards.
Mach 24 1700-1730 feeling odd with some joint pain in knees. Injection shot pain normal as most injuections. 1900 achy 2000 chills started 2100 fever of 99.8 March 25 0015 sweaty and hot fever of 102.5 entire body aches, joint pains knees and arms. Musclar aches all over felt slight nausea 0700 aches continued  fever down 100.2, fatigued slept most of the day. Injection site tender. Drank water ate toast.  1300 fever subsided 98.6 (my normal is 98.2) Took motrin for aches. Rest of day and night slightly achy stiff joints fatigued. March 26 Still achy and stiff. No fever. Took Motrin. By midday had more energy and able to get around and walk. Noticed taking deep breaths was hard to do with out slight pain. Was gone by the 28th.
12/31/2020  vaccination 1/4 I had to leave work. I started to get a bad HA, shaky, 'brain fog'. No fever. Kept feeling extreme nauseous. I went and called dr., said it sounded vaccine related. She did a rapid test; negative.  I was extremely fatigued. She did prescribe Zofran.
Very Painful for a week.  Redness in bicep muscle for a bit over a week.  Then the bicep shrank by 30-40% (still smaller) and tricep shrank by 50% and became very floppy and hangs down. I work out and have had very firm arm muscles. The one with the shot is now very flimsy - not firm at all - hangs down (muscle).  I'm very concerned about what it has done to my muscle(s).
sore throat 1wk hoarse, chest congestion persisted called MD prescribed ATB  10 days;
big knot there and now its black and blue and it's also like ball/could be a blood clot on her hand; Headache; sickness; felt like little vomit; not having a very good appetite; feeling like sinusy; feeling little nauseas; bruise on the top of her hand and then that bruise move to left part of her upper hand; This is a spontaneous report from a contactable consumer (patient) reported that a 53-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ER8727), via an unspecified route of administration on 08Apr2021 (at the age of 53-years-old) as a single dose for covid-19 immunisation. The patient medical history included cardiovascular disease. She has had open heart surgery, a double bypass when she was 44. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 18Mar2021 (at the age of 53-years-old) for covid-19 immunisation, and experienced face got swollen and got red and she think she got wet nose right there swelling a little bit same time her face swollen. Additional medical history included anxiety and depression. Concomitant medications included acetylsalicylic acid, ascorbic acid (ASPIRIN [ACETYLSALICYLIC ACID;ASCORBIC ACID]; atorvastatin; midodrine; metoprolol; clopidogrel; ranolazine; meclozine hydrochloride (MECLIZINE HCL); hydrocortisone; glyceryl trinitrate (NITROGLYCERIN); zinc sulfate (ZINC SULPHATE); gabapentin; colecalciferol (VITAMIN D [COLECALCIFEROL]); and paracetamol (ACETAMINOPHEN); all were taken for an unspecified indication, start and stop date were not reported. Additional concomitant medications included duloxetine taken for depression and anxiety; and alprazolam (XANAX) taken for anxiety; both start and stop date were not reported. On 13Apr2021 5 days after the second vaccination, the patient experienced headache every single day with sickness and felt like little vomit and not having a very good appetite at all. She was feeling "sinusy" but she don't have any sinus issues and then she was feeling little nauseas and then her right hand for some reason she got bruise on the top of her hand and then that bruise move to left part of her upper hand and gotten a big knot there and now its black and blue and it's also like ball; her husband and she think that could be a blood clot on her hand. The outcome of the events was unknown.
Immediate head spins, my face got numb and started tingling, my throat started getting itchy and closing up (like when I'm having an allergic reaction), I was trying to talk to the paramedic and couldn't "collect my thoughts", my head was pounding, my palms were sweating, I feel like I was going to vomit. I told them something was wrong , and I was crying. They were telling me I was probably stressed when I was clearly having some type of reaction
About 15.5 hours after the injection, I had been experiencing some chills, headache, and slightly nauseous, but  barely. I did not feel lightheaded or dizzy that I remember.     I walked to my bathroom, at around 4:15 am I got up and used the bathroom, washed my hands. I fainted and lost consciousness. The next thing I remember I woke up and the light was off in the bathroom.    It is not unusual for me to get up in the middle of the night, and do not believe I was dehydrated or ate less that evening.  Luckily, I believe my butt took the brunt of the fall, as evidenced by the severe soreness there and lack of other areas of pain.
Standard reaction that CDC and Dr. forewarned was possible:   flu like symptoms for 2-3 days:  low grade fever, chills, extreme joint and muscle pain of entire body - particularly both shoulder areas (trapezius and spinatus muscles), mild nausea, extreme fatigue, bad headache, etc and the common red swollen injection area
At 2:10 after 3rd vaccine administered pt stated "I feel dizzy." Mother present at her side; talks to patient. SN observed pt. Flushed, clammy. Pt closed eyes. Immediately mother and nurse assisted patient to floor for comfort measures. Patient unresponsive for 5 seconds, then began to open eyes when mother spoke. SN placed oxygen mask, gave 2 liters NC, check BP @ 100/60. SN noted patient responsive, but not comfortable. Pt alert oriented to person, place, time, paramedics arrived to scene; US taken 100/60 - 70 pulse - Resp 20. Pt with better color, fully up to chair. Mom stated pt with possible epileptic seizures never dx by MD.
Reports dizzy, weak, shuffling gait, and fall that started the day after his Moderna  Vaccine  Narrative: Per report to the PACT team nurse the patient has been weak, dizzy  and having a shuffled gait since 2/18/2021 the day after the Moderna Vaccine. The  patient has not underwent an evaluation and his primary care team has requested  he come in for evaluation.
Per patient approximately 2-3 minutes after injection, patient became pale, diaphoretic, stomach pain. This RN in to exam room at 5 minutes post injection. Patient then states she is having trouble breathing, feels short of breath, coughing/clearing her throat. Benadryl 50 mg given IM, Epinepherine 0.3mg given IM. Patient's condition improved, released home at approximately 1 hour post vaccination and reaction.
6-7-07 Redness and swelling about quarter in size at injection site. Red line about 1 to 1 1/2 inches going down arm from injection site. No fever, no rash, advised cool compresses and Tylenol 6-8-07 symptoms were improving redness is better, swelling is down.
This spontaneous report received from a patient via a social media via company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's past medical history included: possible Covid-19. The patient previously received Covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin, batch number and expiry were not reported) dose not reported, 1 total, administered on an unspecified date for prophylactic vaccination. It was unknown if the patient had adverse events after primary vaccination (dose number in series 1). The patient received Covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin, batch number and expiry were not reported) dose not reported,1 total, administered on an unspecified date for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced felt like crap. The patient mentioned had been around people in house and other places that had Covid-19. The patient thought that the patient had it before shots and after and just felt like cramp. The patient reported, "I took the J and J shot and booster only one I trust. Been around people in my house and other places that had Covid. Think I had it before shots and after. Just felt like crap" (dose number in series 2). The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the felt like crap was not reported. This report was non-serious. This report was associated with product quality complaint: 90000215865. Sender's Comments: V0-Medical assessment comment not required as per standard procedure as the case was assessed as non-serious.
Patient and his Mother were in the vaccination room. appox 30 sec to 1 min following Vaccination patient stated he feels like he is going to pass out and before his mother or administering pharmacist could respond the patient fainted/ lost consciousness for approximately 30seconds
Aug-Sep90 pt vax;  devel measles.  Not confirmed by lab analysis.
received the Shingrix first dose subcutaneously; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of intramuscular formulation administered by other route in a 70-year-old male patient who received Herpes zoster (Shingrix) (batch number 597C4, expiry date 04-AUG-2024) for prophylaxis.   On 24-MAY-2023, the patient received the 1st dose of Shingrix (subcutaneous, left deltoid). On 24-MAY-2023, an unknown time after receiving Shingrix, the patient experienced intramuscular formulation administered by other route (Verbatim: received the Shingrix first dose subcutaneously). The outcome of the intramuscular formulation administered by other route was unknown.   Additional Information: GSK Receipt Date: 25-MAY-2023 The reporter called to enquired that any recommendation if Shingrix was administered subcutaneously instead of Intramuscularly. The reporter reported the patient might have received the Shingrix but it had not been verified if it was.  The reporter stated they believed it was not administered subcutaneously but the patient stated it was.  The reporter did not consent to follow up.  The patient received Shingrix subcutaneously, which led to intramuscular formulation administered by other route.
Vaccine given 11am 7/30. Mild generalized urticaria 7pm same day. NO anaphylactic symptoms. Diet same as always, no previous history of allergy or hives.
About 5 minutes after receiving the vaccine patient approached the pharmacy and said he wasn't feeling well. I asked him if he would like some water and he accepted. He returned to the chair in front of the pharmacy and sipped on the water. He looked like he was pale and breathing more slowly. I went out front to check on him and his breathing appeared labored, he was sweating profusely and he said he felt lightheaded and his hands were tingling. I told him to relax and take some breaths. His hands were very shaky and I took him BP (94/61 and HR 54). At this point I had my technician call 911.  Between the time the paramedics arrived he went unresponsive for approx 20-30 seconds. I yelled his name and slapped his leg. No response. I checked for a pulse and if he was breathing. He did have a pulse and was breathing. After coming to the paramedics arrived and took him to the hospital for evalution.
woke with heart attack like pains in chest. Went to ER. had an EKG, chest x-rays and blood drawn and urine sample.  Was told  "slight" inflammation around heart.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 24-MAR-2015, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB 10 microgram/1 ml (lot#J010613, expiration date 11-JUN-2016). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion four times. The total cumulative excursion time (hour), the lowest recorded temperature (Fahrenheit degree/Celsius) and the type of excursion (R/F) for each time were 48, 1 and R; 48, 0 and R;  72, unknown and R; 24 -1 and R. The storage criteria was refrigerator (R). This is one of several reports received from the same source. Additional information has been requested.
Persistent and long lasting fevers up to 105 degrees F; multiple doctors, ER, and urgent care visits. Diagnoses included recurrent ear infections, upper respiratory infections, and one urinary tract infection. Antibiotics prescribed almost continually. Symptoms included high, long lasting fever (usually 5-8 days), fatigue, weakness, loss of appetite. After months of recurrent infections, blood test ordered on December 10, followed by instruction to report to the emergency room. Additional bloodwork results indicated acute lymphoblastic leukemia, admitted to the hospital, began chemotherapy, discharged in December 19. Ongoing treatment for leukemia.
Patient received FLUZONE on 9/9/11 & still report muscle stiffness on 9/26/11.
Headache Narrative:  Headaches, night chills , swollen arm/redness/warm to touch.